Corporate

  • February 12, 2026

    Maxeon Dodges Investor Suit Over Financial Disclosures

    Maxeon Solar Technologies has escaped a shareholder class action accusing it of misleading investors about its liquidity issues, with a California federal judge ruling that none of the challenged statements in the suit were shown to be false or misleading.

  • February 12, 2026

    E-Commerce Co. Opensend Sued For Docs On Insider Moves

    A stockholder and director of e-commerce support venture Opensend Inc. has sued the business for books and records in Delaware's Court of Chancery, citing concerns about alleged subverting of financial controls, hiring of the company CEO's wife and business dealings with the CEO's brother.

  • February 12, 2026

    2nd Circ. Seems Wary Of Restarting Norfolk Derailment Suit

    The Second Circuit appeared skeptical Thursday of investors' bid to revive a proposed class action against Norfolk Southern alleging that the company botched disclosures about how an efficiency plan might cause derailments, as judges seemed open to a lower court's interpretation that railroad statements about safety were puffery.

  • February 12, 2026

    Foley & Lardner Adds Gray Reed Construction Pro In Dallas

    Foley & Lardner LLP has boosted the manufacturing sector of its construction practice group with a Dallas-based partner who came from Gray Reed & McGraw LLP.

  • February 12, 2026

    Investment Co. Sues In Del. Over $3.5M Manhattan Condo Deal

    A New York investment firm has sued the developers of a luxury Manhattan condominium tower in the Delaware Chancery Court, seeking either title to a unit in the building or more than $3.5 million in principal and returns that the investor says it is owed under a pair of agreements.

  • February 11, 2026

    AbbVie Sues Medicaid, HHS Over Botox Fair Price Controls

    AbbVie Inc. on Wednesday asked a D.C. federal court to block the Centers for Medicare and Medicaid Services from controlling the price of Botox under the Inflation Reduction Act, arguing the cosmetic drug and migraine treatment should be excluded from the controls because it's a "plasma-derived" product.

  • February 11, 2026

    7th Circ. May Seek Ill. Justices' Input In Hyundai BIPA Row

    A Seventh Circuit panel on Wednesday appeared skeptical about whether Hyundai Motor America had any control over biometric data captured by cameras installed in certain Hyundai vehicles and how a proposed class of drivers was injured under Illinois' biometric privacy law, but one judge suggested the case presents a question the state's top court may need to answer.

  • February 11, 2026

    'The Shoe Is On The Other Foot': Judge Needles Meta In MDL

    A California federal judge presiding over social media addiction multidistrict litigation Wednesday criticized Meta's bid to push newly filed arbitration demands into court, saying she doesn't have jurisdiction over those claims and noting "big companies" are always insisting on arbitration, but "when they don't like the fact that they're arbitrating, they complain about it."

  • February 11, 2026

    AGs Warn Cos. Plastic Initiatives May Break Competition Laws

    The attorneys general of 10 red states have warned 80 corporations that their purported involvement in organizations aiming to reduce plastic waste might run afoul of antitrust and consumer protection laws, following similar competition-focused actions targeting environmental and diversity groups at the state and federal levels.

  • February 11, 2026

    Mobile Home Orgs Can't Bring Class Suit, Fla. Panel Says

    A Florida panel ruled in a Wednesday split decision that two mobile homeowners' associations can't combine to bring one class action alleging unreasonable rent increases, citing state court rules that allow only one association to bring claims on behalf of its own members. 

  • February 11, 2026

    Pfizer, SEC Reach $29M Deal In Insider Trading Fund Dispute

    Pfizer and the U.S. Securities and Exchange Commission have jointly asked a New York federal judge to allow $29 million out of the roughly $75.2 million distribution leftover from a $602 million insider trading deal to be paid out to a Pfizer subsidiary.

  • February 11, 2026

    Blockbuster's TM Legacy Tested By Dispute Over Deer Feed

    Once a titan in U.S. retail, the Blockbuster brand is embroiled in an unexpected trademark battle with a Mississippi-based animal feed company that it accuses of trying to exploit the legacy of the once-ubiquitous video rental chain.

  • February 11, 2026

    CEO Criticizes 'Crazy Lawyers' In $5M Financial Adviser Feud

    The chief executive officer of Prime Capital Investment Advisors LLC on Wednesday testified that he emailed a rival CEO during litigation to warn him that "crazy lawyers" could be burning millions of dollars to fight an unfair trade practices case Prime believed involved business worth $50,000 to $100,000.

  • February 11, 2026

    Disney To Pay $2.75M In Record Deal Under Calif. Privacy Law

    California's attorney general announced Wednesday that his office has secured its largest deal yet under the state's data privacy law, with entertainment giant Disney agreeing to pay $2.75 million and overhaul its opt-out mechanisms to resolve claims that it failed to allow consumers to completely stop the sale and sharing of their personal data. 

  • February 11, 2026

    Del. Justices Grapple Over Truth Social Share Math

    An attorney for the firm that helped launch Donald Trump's social media company told Delaware's justices Wednesday that a vice chancellor erred in requiring the venture to "prove a negative" in calculations of investor stakes in the run-up to the venture's special purpose acquisition company transaction.

  • February 11, 2026

    Estee Lauder Hits Walmart With TM Suit Alleging Copycats

    Estee Lauder hit Walmart with a trademark infringement suit in California federal court Monday, accusing it of hawking copycat versions of its luxury personal care products, cosmetics and fragrance collections sold under popular brands including Clinique, La Mer and Tom Ford. 

  • February 11, 2026

    House OKs Ending Canada Tariffs After GOP Block Fails

    The U.S. House of Representatives approved a resolution Wednesday evening that would end President Donald Trump's tariffs on Canadian imports, a day after Republican lawmakers were unable to pass a measure blocking that kind of effort.

  • February 11, 2026

    Miami World Cup Counsel Share Look At Prep Work, Impact

    Counsel representing the FIFA World Cup's Miami Host Committee gave Law360 an inside look at their multifaceted work preparing for the upcoming event, which organizers say could have the economic impact of multiple Super Bowls.

  • February 11, 2026

    Boeing Aims To Nix Polish Airline's $8.4M Damages Report

    Boeing has asked a Seattle federal judge to exclude an $8.4 million "eleventh hour" damages report prepared by a Polish airline's expert, arguing it is not only untimely but also irrelevant to testimony the jury will hear.

  • February 11, 2026

    MrBeast, Ex-IT Worker Near Deal In Trade Secret Theft Dispute

    YouTube star MrBeast's media company has told a North Carolina federal judge it has reached a settlement in principle to resolve its lawsuit accusing a former IT contractor of downloading thousands of confidential company documents ahead of his firing and leaving behind hidden cameras throughout the company's offices.

  • February 11, 2026

    Egypt's 'Social Law' Doesn't Endorse Bribery, Jury Told

    Attorneys for a former Corsa Coal executive on trial for allegedly passing bribes sought to undermine an expert witness's opinions that bribery was illegal in Egypt, confronting him with law review articles he'd written that said corruption was commonly accepted and had become the "social law."

  • February 11, 2026

    Pegasystems Settles Mass. Shareholder Actions For $7M

    Pegasystems has agreed to pay $7 million to settle three shareholder derivative suits in Massachusetts state and federal courts alleging the software company's top officials sat on details of a 2020 trade secrets suit that led to a now-overturned $2 billion verdict.

  • February 11, 2026

    Beasley Allen Wants Talc DQ Paused Pending High Court Appeal

    Hundreds of women who claim their ovarian cancer was caused by Johnson & Johnson's talcum powder risk appearing in an upcoming trial without their preferred counsel from the Beasley Allen Law Firm, unless a New Jersey state court stays an order disqualifying the firm, it said.

  • February 11, 2026

    Stockholder Sues AI Firm Airship In Del. For Books, Records

    A California stockholder of a California-based artificial intelligence communication company has filed suit in the Delaware Chancery Court seeking to force the agency to turn over financial and board records, alleging that it has improperly limited his access to information needed to value his shares.

  • February 11, 2026

    Paul Hastings Adds Ex-Norton Rose Investment Funds Pro

    Paul Hastings LLP has added an investment funds specialist who previously worked with Norton Rose Fulbright as a partner in its Chicago office, the firm announced Wednesday.

Expert Analysis

  • Opinion

    CFIUS Must Adapt To Current Foreign Investment Realities

    Author Photo

    To continue protecting the U.S.’ long-term strategic and economic interests, the Committee on Foreign Investment in the United States should implement practical enhancements that leverage technology, expertise and clear communication, and enable it to keep pace with evolving demands, says attorney Sohan Dasgupta.

  • Protecting Sensitive Data During Congressional Inquiries

    Author Photo

    With the 2026 midterm elections potentially set to shift control of one or both houses of Congress, entities must proactively plan for the prospect of new congressional investigations, and adopt strategic, effective and practical measures to mitigate risks related to disclosure of sensitive information, say attorneys at Crowell & Moring.

  • Where PCAOB Goes Next After A Year Of Uncertainty

    Author Photo

    The Public Company Accounting Oversight Board will likely bring fewer enforcement matters in 2026, reflecting a notable change in board priorities following the change in administrations, say Robert Cox and Nicole Byrd at Whiteford Taylor and Matthew Rogers at Bridgehaven Consulting.

  • Ambiguity Remains On Anti-DEI Grant Conditions

    Author Photo

    Although a recent decision in City of Chicago and City of Saint Paul v. U.S. Department of Justice temporarily halts enforcement of anti-DEI conditions in federal grant applications, and echoes recent decisions in similar cases, companies remain at risk until the term “illegal DEI” is clarified, say attorneys at Moore & Van Allen.

  • Series

    Teaching Logic Makes Me A Better Lawyer

    Author Photo

    Teaching middle and high school students the skills to untangle complicated arguments and identify faulty reasoning has made me reacquaint myself with the defined structure of thought, reminding me why logic should remain foundational in the practice of law, says Tom Barrow at Woods Rogers.

  • Series

    Law School's Missed Lessons: Practicing Resilience

    Author Photo

    Resilience is a skill acquired through daily practices that focus on learning from missteps, recovering quickly without internalizing defeat and moving forward with intention, says Nicholas Meza at Quarles & Brady.

  • Takeaways From The DOJ Fraud Section's 2025 Year In Review

    Author Photo

    Former acting Principal Deputy Chief Sean Tonolli of the U.S. Department of Justice's Fraud Section, now at Cahill Gordon, analyzes key findings from the section’s annual report — including the changes implemented to adapt to the new administration’s priorities — and lays out what to watch for this year.

  • What An Uptick In Shareholder Activism Means For Banking

    Author Photo

    With increasing bank M&A activity, activists are becoming more focused on larger banking institutions, but there are ways banks can begin to prepare in case they need to defend against activist campaigns, say attorneys at Debevoise.

  • Anticipating The SEC's Cybersecurity Focus After SolarWinds

    Author Photo

    While the U.S. Securities and Exchange Commission's recent voluntary dismissal of its enforcement action against SolarWinds Corp. and its chief information security officer marks a significant victory for the defendants, it does not mean the SEC is done bringing cybersecurity cases, say attorneys at MoFo.

  • Limiting Worker Surveillance Risks Amid AI Regulatory Shifts

    Author Photo

    With workplace surveillance tools becoming increasingly common and a recent executive order aiming to preempt state-level artificial intelligence enforcement, companies may feel encouraged to expand AI monitoring, but the legal exposure associated with these tools remains, say attorneys at MoFo.

  • How Insurers Are Wording AI Exclusions

    Author Photo

    Artificial intelligence exclusions are now available for use in insurance policies, meaning corporate risk managers must determine how those exclusions are interpreted and applied, and how they define AI, says David Kroeger at Jenner & Block.

  • Traditional FCA Enforcement Surges Amid Shifting Priorities

    Author Photo

    The U.S. Department of Justice’s January report on False Claims Act enforcement in fiscal year 2025 reveals that while the administration signaled its intent to expand FCA enforcement into new areas such as tariffs, for now the greatest exposure remains in traditional areas like healthcare — in which the risk is growing, say attorneys at Debevoise.

  • How 3 CFTC Letters Overhauled Digital Asset Guidance

    Author Photo

    The U.S. Commodity Futures Trading Commission recently issued three letters providing guidance for the use of digital assets in derivatives markets, clarifying the applicability of CFTC regulations across numerous areas of digital asset activities and leading to the development of standards to allow market participants to post digital assets as collateral, say attorneys at Morgan Lewis.

  • How 2 Tech Statutes Are Being Applied To Agentic AI

    Author Photo

    The application of the Computer Fraud and Abuse Act and the California Invasion of Privacy Act to agentic artificial intelligence is still developing, but recent case law, like Amazon's lawsuit against Perplexity in California federal court, provides some initial guidance for companies developing or deploying these technologies, say attorneys at Weil.

  • FTC Focus: Testing Joint Enforcement Over Loyalty Programs

    Author Photo

    The Federal Trade Commission's case against Syngenta can be understood both as a canary for further scrutiny over loyalty-discount practices and a signal of the durability of joint federal-state antitrust enforcement, with key takeaways for practitioners and those subject to regulatory antitrust scrutiny alike, say attorneys at Proskauer.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Corporate archive.